Literature DB >> 21375461

Progress in mining the human proteome for disease applications.

Sam Hanash1.   

Abstract

Currently available technologies allow in-depth analysis of multiple facets of the proteome that have clinical relevance and that complement current genomics-based approaches. Although some progress has been made in our knowledge of the human proteome in health and in disease, there is an urgent need to chart a coherent road map with clearly defined milestones to guide proteomics efforts. Areas of emphasis include: (1) building resources, (2) filling gaps in our understanding of biological variation, and (3) systematically characterizing proteome alterations that occur in well-defined disease states, all of which require an organized and collaborative effort.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375461      PMCID: PMC3118795          DOI: 10.1089/omi.2010.0111

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  53 in total

Review 1.  HUPO initiatives relevant to clinical proteomics.

Authors:  Sam Hanash
Journal:  Mol Cell Proteomics       Date:  2004-01-27       Impact factor: 5.911

Review 2.  Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens.

Authors:  Marta Sanchez-Carbayo
Journal:  Tumour Biol       Date:  2010-01-21

3.  From cells, secrets of the secretome leak out.

Authors:  Mike May
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

Review 4.  Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.

Authors:  Hans Voshol; Markus Ehrat; Jens Traenkle; Eric Bertrand; Jan van Oostrum
Journal:  FEBS J       Date:  2009-10-26       Impact factor: 5.542

5.  jmzML, an open-source Java API for mzML, the PSI standard for MS data.

Authors:  Richard G Côté; Florian Reisinger; Lennart Martens
Journal:  Proteomics       Date:  2010-04       Impact factor: 3.984

6.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Authors:  Marcia L Stefanick; Garnet L Anderson; Karen L Margolis; Susan L Hendrix; Rebecca J Rodabough; Electra D Paskett; Dorothy S Lane; F Allan Hubbell; Annlouise R Assaf; Gloria E Sarto; Robert S Schenken; Shagufta Yasmeen; Lawrence Lessin; Rowan T Chlebowski
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

Review 7.  Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery.

Authors:  Laura Beretta
Journal:  Cancer Lett       Date:  2009-02-15       Impact factor: 8.679

8.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Authors:  Jane A Cauley; John Robbins; Zhao Chen; Steven R Cummings; Rebecca D Jackson; Andrea Z LaCroix; Meryl LeBoff; Cora E Lewis; Joan McGowan; Joan Neuner; Mary Pettinger; Marcia L Stefanick; Jean Wactawski-Wende; Nelson B Watts
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

9.  Quantitative mass spectrometry-based proteomics reveals the dynamic range of primary mouse astrocyte protein secretion.

Authors:  Todd M Greco; Steven H Seeholzer; Adrian Mak; Lynn Spruce; Harry Ischiropoulos
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

Review 10.  Protein arrays as tools for serum autoantibody marker discovery in cancer.

Authors:  Gregor Kijanka; Derek Murphy
Journal:  J Proteomics       Date:  2009-03-01       Impact factor: 4.044

View more
  4 in total

Review 1.  The Promise of Proteomics in the Study of Oncogenic Viruses.

Authors:  Alison A McBride
Journal:  Mol Cell Proteomics       Date:  2017-01-19       Impact factor: 5.911

2.  Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers.

Authors:  Ginette Tardif; Frédéric Paré; Clarisse Gotti; Florence Roux-Dalvai; Arnaud Droit; Guangju Zhai; Guang Sun; Hassan Fahmi; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2022-05-23       Impact factor: 5.606

Review 3.  Challenges of deciphering gastric cancer heterogeneity.

Authors:  Petra Hudler
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 4.  Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.

Authors:  Petra Hudler; Nina Kocevar; Radovan Komel
Journal:  ScientificWorldJournal       Date:  2014-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.